Caricamento...
Interstitial lung disease induced by docetaxel and ramucirumab chemotherapy after nivolumab treatment
Three men (aged 64, 65, and 67 years) with advanced lung cancer who had been treated with nivolumab developed interstitial lung disease (ILD) during chemotherapy with docetaxel and ramucirumab. The treatment was clinically effective; however, the patients experienced immune‐related adverse effects d...
Salvato in:
| Pubblicato in: | Respirol Case Rep |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7176744/ https://ncbi.nlm.nih.gov/pubmed/32337046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.564 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|